JAENS PHARMACEUTICAL INDUSTRIES products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Sheikhupura · Pakistan
Sheikhupura-based pharmaceutical manufacturer established in 2004 with registered products across oral, injectable, ophthalmic and topical dosage forms.
JAENS PHARMACEUTICAL INDUSTRIES products in Pakistan
JAENS PHARMACEUTICAL INDUSTRIES PVT LTD has 60 medicine presentations registered in Pakistan under 35 brands, covering 34 generic medicines. Most of its products are in Anti-infectives, Cardiovascular and Gastrointestinal & hepatology. Its brands with the most registered strengths and packs are AZAL (Azithromycin), Dazo (Metronidazole), Dicip (Ciprofloxacin) and Dongcain (Lidocaine). 60 products have an official DRAP price on MedInfoBase. See all 35 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Jaens Pharmaceutical Industries (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer
- Address
- 28 KM Lahore-Sheikhupura Road, Sheikhupura, Pakistan
- Website
- jaenspharma.com ↗
- info@jaenspharma.com
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 75%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where JAENS PHARMACEUTICAL INDUSTRIES PVT LTD is priced against the market
52 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| ALTIM | Timolol | 0.5 % | Ophthalmic drops | 5ml | 032620 | PKR 179.51 | PKR 35.90/mL | 🔒 Pharma Pro |
| ANTICIP Ear | Ciprofloxacin | 0.3 % | Ear drops | 5ml | 050100 | PKR 189.48 | PKR 37.90/mL | 🔒 Pharma Pro |
| AZAL | Azithromycin | 250 mg | Tablet | 1x10's | 032650 | PKR 427.65 | PKR 42.77/tablet | 🔒 Pharma Pro |
| AZAL | Azithromycin | 500 mg | Tablet | 6's | 106189 | PKR 412.68 | PKR 68.78/tablet | 🔒 Pharma Pro |
| AZAL | Azithromycin | 250 mg | Capsule | 6's | 108167 | PKR 229.61 | PKR 38.27/capsule | 🔒 Pharma Pro |
| BEXATOL | Betaxolol | 0.5% | Ophthalmic drops | 5ml | 106517 | PKR 183.12 | PKR 36.62/mL | No comparator |
| CALARIDE | Clarithromycin | 250 mg | Tablet | 1x10's | 032654 | PKR 488.74 | PKR 48.87/tablet | 🔒 Pharma Pro |
| CALARIDE | Clarithromycin | 500 mg | Tablet | 1x10's | 032655 | PKR 887.56 | PKR 88.76/tablet | 🔒 Pharma Pro |
| CIPOTROL | Calcipotriol | 50 mcg | Cream | 30gm | 106513 | PKR 1,076.87 | PKR 35.90/g | No comparator |
| Cipotrol | Calcipotriol | 50 mcg | Ointment | 30gm | 111601 | PKR 988.87 | PKR 32.96/g | No comparator |
| CYKOVIR | Aciclovir | 3.0% | Ophthalmic ointment | 4.5gm | 096621 | PKR 238.03 | PKR 52.90/g | No comparator |
| Cykovir | Aciclovir | 200 mg | Tablet | 10's | 109705 | PKR 282.53 | PKR 28.25/tablet | 🔒 Pharma Pro |
| Dazo | Metronidazole | 200 mg | Tablet | 20x10's | 036451 | PKR 266.09 | PKR 1.33/tablet | 🔒 Pharma Pro |
| Dazo | Metronidazole | 400 mg | Tablet | 2x10's | 036452 | PKR 38.01 | PKR 1.90/tablet | 🔒 Pharma Pro |
| Dazo | Metronidazole | 400 mg | Tablet | 10x10's | 036452 | PKR 190.05 | PKR 1.90/tablet | 🔒 Pharma Pro |
| DENATACIN | Natamycin | 5% (50 mg/mL) | Ophthalmic drops | 15ml | 041783 | PKR 353.04 | PKR 23.54/mL | No comparator |
| Dicip | Ciprofloxacin | 3 mg/mL (0.3%) | Ophthalmic drops | 5ml | 032621 | PKR 189.48 | PKR 37.90/mL | 🔒 Pharma Pro |
| Dicip | Ciprofloxacin | 250 mg | Tablet | 1x10's | 076815 | PKR 259.29 | PKR 25.93/tablet | 🔒 Pharma Pro |
| Dicip | Ciprofloxacin | 500 mg | Tablet | 1x10's | 077130 | PKR 428.82 | PKR 42.88/tablet | 🔒 Pharma Pro |
| Dongcain | Lidocaine | 1% | Injection | 3.5ml | 074269 | PKR 4.10 | PKR 1.17/mL | 🔒 Pharma Pro |
| Dongcain | Lidocaine | 1 % | Injection | 2ml | 074269 | PKR 4.10 | PKR 2.05/mL | 🔒 Pharma Pro |
| Dongcain | Lidocaine | 1% | Injection | 1ml | 074269 | PKR 4.10 | PKR 4.10/mL | 🔒 Pharma Pro |
| Hyperasl Eye DropsRegistry verified | Sodium Chloride | — | — | — | 011217-EXOfficial source ↗ | No indexed price | — | — |
| Jamide | Loperamide HCl | 2 mg | Capsule | 6x10's | 084027 | PKR 378.96 | PKR 6.32/capsule | 🔒 Pharma Pro |
| JANPLATE | Clopidogrel | 75 mg | Tablet | 10's | 096707 | PKR 236.34 | PKR 23.63/tablet | 🔒 Pharma Pro |
| Jaqcy | Hydroxychloroquine | 200 mg | Tablet | 50's | 108024 | PKR 675.31 | PKR 13.51/tablet | 🔒 Pharma Pro |
| Jaqcy | Hydroxychloroquine | 200 mg | Tablet | 30's | 108024 | PKR 405.18 | PKR 13.51/tablet | 🔒 Pharma Pro |
| Jasortin | Atorvastatin | 10 mg | Tablet | 10's | 109708 | PKR 183.64 | PKR 18.36/tablet | 🔒 Pharma Pro |
| Jasortin | Atorvastatin | 20 mg | Tablet | 10's | 109709 | PKR 310.79 | PKR 31.08/tablet | 🔒 Pharma Pro |
| Jasortin | Atorvastatin | 40 mg | Tablet | 10's | 109710 | PKR 515.63 | PKR 51.56/tablet | 🔒 Pharma Pro |
| Jemvartan 10/160 mg TabletRegistry verified | Amlodipine besylate eq to amlodipine, Valsartan | — | — | — | 109698Official source ↗ | No indexed price | — | — |
| Jemvartan 5/160 mg Tablet.Registry verified | Amlodipine besylate eq to amlodipine, Valsartan | — | — | — | 109697Official source ↗ | No indexed price | — | — |
| Jemvartan 5/80 mg Tablet.Registry verified | Amlodipine besylate eq to amlodipine, Valsartan | — | — | — | 109696Official source ↗ | No indexed price | — | — |
| Jencef | Cefixime | 400 mg | Capsule | 5's | 089414 | PKR 437.51 | PKR 87.50/capsule | 🔒 Pharma Pro |
| Jencef | Cefixime | 100 mg/5 mL | Suspension | 30ml | 089415 | PKR 279.86 | PKR 9.33/mL | 🔒 Pharma Pro |
| Jeronum | Meropenem | 1 g | IV injection | 1's | 097639 | PKR 3,001.36 | PKR 3,001.36/vial/unit | 🔒 Pharma Pro |
| Jeronum | Meropenem | 500 mg | IV injection | 1's | 097640 | PKR 1,605.73 | PKR 1,605.73/vial/unit | 🔒 Pharma Pro |
| JOXY | Doxycycline | 100 mg | Tablet | 5x10's | 034319 | PKR 398.90 | PKR 7.98/tablet | 🔒 Pharma Pro |
| JOXY | Doxycycline | 100 mg | Tablet | 10x10's | 034319 | PKR 777.86 | PKR 7.78/tablet | 🔒 Pharma Pro |
| Lebun | Levobunolol | 0.5% | Ophthalmic drops | 5ml | 103498 | PKR 123.07 | PKR 24.61/mL | No comparator |
| LEVOJAENS | Levofloxacin | 250 mg | Tablet | 10's | 091438 | PKR 485.33 | PKR 48.53/tablet | 🔒 Pharma Pro |
| LEVOJAENS | Levofloxacin | 500 mg | Tablet | 10's | 091439 | PKR 807.59 | PKR 80.76/tablet | 🔒 Pharma Pro |
| Lized | Linezolid | 600 mg | Tablet | 12's | 111599 | PKR 3,610.78 | PKR 300.90/tablet | 🔒 Pharma Pro |
| Methlepred | Methylprednisolone aceponate | 0.1 % | Ointment | 5gm | 111602 | PKR 114.65 | PKR 22.93/g | No comparator |
| MOXBAY | Moxifloxacin | 400 mg | Tablet | 5's | 096708 | PKR 801.84 | PKR 160.37/tablet | 🔒 Pharma Pro |
| NOLAR | Loratadine | 10 mg | Tablet | 1x10's | 032644 | PKR 143.61 | PKR 14.36/tablet | 🔒 Pharma Pro |
| OFVIN | Ofloxacin | 3 mg/mL (0.3%) | Ophthalmic drops | 5ml | 032635 | PKR 159.57 | PKR 31.91/mL | No comparator |
| Recon | Itraconazole | 100 mg | Capsule | 4's | 089464 | PKR 605.22 | PKR 151.31/capsule | 🔒 Pharma Pro |
| Rethier | Artemether | 80 mg/mL | Injection | 6x1ml | 071478 | PKR 1,196.70 | PKR 199.45/mL | 🔒 Pharma Pro |
| Revatin 20mg Tablets.Registry verified | Rosuvastatin (as Calcium) | — | — | — | 109711Official source ↗ | No indexed price | — | — |
All 35 JAENS PHARMACEUTICAL INDUSTRIES brands in Pakistan
- ALTIM Timolol · 0.5 % drops
- ANTICIP Ear Ciprofloxacin · 0.3 % drops
- AZAL Azithromycin · 250 mg tablet, 250 mg capsule, 500 mg tablet
- BEXATOL Betaxolol · 0.5% drops
- CALARIDE Clarithromycin · 250 mg tablet, 500 mg tablet
- CIPOTROL Calcipotriol · 50 mcg cream, 50 mcg ointment
- Cykovir Aciclovir · 200 mg tablet, 3.0% ointment
- Dazo Metronidazole · 200 mg tablet, 400 mg tablet
- DENATACIN Natamycin · 5% (50 mg/mL) drops
- Dicip Ciprofloxacin · 250 mg tablet, 3 mg/mL (0.3%) drops, 500 mg tablet
- Dongcain Lidocaine · 1 % injection, 1% injection
- Jamide Loperamide HCl · 2 mg capsule
- JANPLATE Clopidogrel · 75 mg tablet
- Jaqcy Hydroxychloroquine · 200 mg tablet
- Jasortin Atorvastatin · 10 mg tablet, 20 mg tablet, 40 mg tablet
- Jencef Cefixime · 100 mg/5 mL suspension, 400 mg capsule
- Jeronum Meropenem · 1 g injection, 500 mg injection
- JOXY Doxycycline · 100 mg tablet
- Lebun Levobunolol · 0.5% drops
- LEVOJAENS Levofloxacin · 250 mg tablet, 500 mg tablet
- Lized Linezolid · 600 mg tablet
- Methlepred Methylprednisolone aceponate · 0.1 % ointment
- MOXBAY Moxifloxacin · 400 mg tablet
- NOLAR Loratadine · 10 mg tablet
- OFVIN Ofloxacin · 3 mg/mL (0.3%) drops
- Recon Itraconazole · 100 mg capsule
- Rethier Artemether · 80 mg/mL injection
- RINTER Cetirizine · 10 mg tablet
- Roficef Ceftriaxone · 1 g injection, 500 mg injection
- Sempol Esomeprazole · 20 mg capsule, 40 mg capsule
- SIZINE Silver sulfadiazine · 1 % cream
- Stomer Omeprazole · 20 mg capsule, 40 mg capsule
- THAITAN Losartan · 100 mg tablet, 25 mg tablet, 50 mg tablet
- TROZOL Letrozole · 2.5 mg tablet
- Water Water for Injection · 10 mL injection, 2 mL injection, 5 mL injection
JAENS PHARMACEUTICAL INDUSTRIES: common questions
How many products does JAENS PHARMACEUTICAL INDUSTRIES have in Pakistan?
JAENS PHARMACEUTICAL INDUSTRIES PVT LTD has 60 registered medicine presentations in Pakistan, sold under 35 brands and covering 34 generic medicines.
What are the main brands of JAENS PHARMACEUTICAL INDUSTRIES?
By number of registered strengths and packs, its largest brands are AZAL (Azithromycin), Dazo (Metronidazole), Dicip (Ciprofloxacin), Dongcain (Lidocaine) and Jasortin (Atorvastatin). This is not a sales ranking.
Which therapy areas does JAENS PHARMACEUTICAL INDUSTRIES cover?
The most products are in Anti-infectives (33), Cardiovascular (6), Gastrointestinal & hepatology (5), Ophthalmology (3) and Anesthesia & critical care (3).
Where can I see JAENS PHARMACEUTICAL INDUSTRIES medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.